Navigation Links
Experts Issue Guidelines for Treating Irritable Bowel Syndrome
Date:8/8/2014

By
HealthDay Reporter

FRIDAY, Aug. 8, 2014 (HealthDay News) -- Newly released guidelines for the treatment of irritable bowel syndrome and a type of constipation known as chronic idiopathic constipation reveal a number of proven treatments for these two common conditions.

"There's a greater variety of approaches which reflect a greater understanding of the disorders," said guidelines co-author Dr. Eamonn Quigley, chief of the division of gastroenterology and hepatology at Houston Methodist Hospital.

"We now have a better opportunity to improve the lives of our patients," Quigley said.

The guidelines are published in the August issue of the American Journal of Gastroenterology.

An estimated 5 percent to 15 percent of the world's population has irritable bowel syndrome, a condition that can cause symptoms such as abdominal pain, diarrhea or constipation, cramping and bloating, and gas. It can affect people at any age but is especially common when people are in their 20s and 30s, Quigley said.

The condition can be difficult to diagnose because other conditions share the same symptoms. Unlike other conditions, however, there's no specific diagnostic test for irritable bowel syndrome, he noted. Physicians must rely purely on symptoms to make the diagnosis.

The new guidelines, released this week by the American College of Gastroenterology, say there's evidence to support the following treatments for irritable bowel syndrome:

  • Fiber (psyllium especially when compared to bran)
  • Probiotics
  • An antibiotic called rifaximin (Rifagut)
  • Medications known as linaclotide (Linzess) and lubiprostone (Amitiza)

The irritable bowel syndrome guidelines also say that research has boosted the case for using antidepressant medications and psychological therapy.

Probiotics are a hot topic in medicine. Quigley said research supports their use, but it's not clear which ones are best. "We need more studies comparing doses and preparations, and there hasn't been a lot of that done," he said. Still, probiotics are safe and patients tolerate them well, he noted.

"In regards to specifics, patients have to talk to their doctor," Quigley said.

Dr. William Chey, a gastroenterologist and professor of medicine at the University of Michigan, agreed that it's difficult to decide which probiotic product to recommend. He said one possibility is the product known as Align, which is widely available.

However, the guidelines indicate that there's not enough evidence to support the use of prebiotics (components of food that can't be digested and promote healthy bacteria) and synbiotics (products that combine probiotics and prebiotics).

As for diet, Quigley said there's some evidence that gluten-free diets and so-called "FODMAP" diets can help reduce symptoms of irritable bowel syndrome. FODMAP diets cut out potentially troublesome foods, such as certain added sugars, and then reintroduce them to the diets of patients to help figure out which ones cause symptoms.

Chey said the guidelines slightly understate the value of treatments that involve changing diet since there's evidence that "diet plays a role in the development of the condition and has a role in treatment."

For patients with chronic idiopathic constipation, Quigley said, "there are a lot of relatively simple and relatively inexpensive treatments that work for constipation, and most of them are pretty safe."

Chronic idiopathic constipation is long-term constipation that doesn't have a known cause. Approximately 10 percent to 15 percent of the general population suffers from this condition.

The guidelines for chronic idiopathic constipation strongly recommend the use of fiber supplements plus laxatives such as polyethylene glycol (MiraLax), lactulose (Generlac), sodium picosulfate and bisacodyl (Dulcolax).

The guidelines also strongly recommend linaclotide (Linzess) and lubiprostone (Amitiza), which also appear in the recommendations to treat irritable bowel syndrome, and prucalopride (Resolor).

Some of these drugs are available over the counter, Quigley said. Prescription drugs are available for people with more severe cases of constipation, he said.

More information

For more about irritable bowel syndrome, try the U.S. National Institute of Diabetes and Digestive and Kidney Diseases.

SOURCES: Eamonn Quigley, M.D., chief, division of gastroenterology and hepatology, and professor of medicine, Weill Cornell Medical College, Houston Methodist Hospital; William Chey, M.D., gastroenterologist and professor of medicine, University of Michigan, Ann Arbor, Mich.; August 2014, American Journal of Gastroenterology


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Experts Offer Advice After Yankee Pitchers Trampoline Injury
2. NYU Langone experts present research, clinical advances at neurosurgeons meeting
3. Red Tide Likely in New England This Season, Experts Warn
4. No Proof That Gum Disease Causes Heart Disease, Experts Say
5. Leading experts on congenital muscular dystrophy convene at University of Nevada, Reno
6. Glaucoma Need Not Steal Sight, Experts Say
7. Healthy Behaviors Extend Life After Cancer, Experts Say
8. Routine Kidney Disease Screening Not Worthwhile, Experts Say
9. Columbia University Medical Center and NY-Presbyterian experts at APA meeting
10. Aim Skin Cancer Warnings at the Young, Too, Experts Say
11. Experts call for clinical trials to test non-skeletal benefits of vitamin D
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Experts Issue Guidelines for Treating Irritable Bowel Syndrome
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... , ... May 27, 2016 , ... ... scholarships to students studying complementary medicine. Allison Outerbridge is this year’s Life ... award on May 18 at the university’s Student Leadership Awards ceremony. , Outerbridge ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
(Date:5/26/2016)... ... 2016 , ... The Woodlands at John Knox Village , Florida’s first ... for living and healing, celebrated its grand opening, today. The Woodlands at John Knox ... by Empowered Staff. , “This is an incredibly fulfilling time for John Knox Village ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James Maisel will ... Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the Farmingdale Public ... Retina Group of New York , is a Board Certified ophthalmologist who ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 24, 2016 ARANZ Medical  Ltd ... healthcare sector, has been named the Coretex Hi-Tech Emerging Company ... Dr Bruce Davey , CEO of ARANZ ...  It,s really good to be recognised for the work we ... are used in 35 countries around the world from Sub-Saharan ...
(Date:5/24/2016)... BioMarketing as senior vice president of sales, announced Andrea Heslin Smiley , VMS ... company,s business development and sales team, exploring new opportunities for VMS to empower patients ... ... ... ...
(Date:5/24/2016)... May 24, 2016 ... , la première endoprothèse à double ... à l,intervention portant sur les membres inférieurs ... OrbusNeich, entreprise mondiale spécialisée dans la ... la vie, a élargi son portefeuille pour ...
Breaking Medicine Technology: